Last reviewed · How we verify
NCT02723396: SA&M-I
Sleep, Awake & Move - Part I
trial in Idiopathic Parkinson Disease in 67 participants. Completed in 9 February 2024.
31 May 2019
Quick facts
| Lead sponsor | Neurocenter of Southern Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 67 |
| Start date | 16 March 2016 |
| Primary completion | 31 May 2019 |
| Estimated completion | 9 February 2024 |
| Sites | 1 location across Switzerland |
Conditions studied
- Idiopathic Parkinson Disease — all drugs for Idiopathic Parkinson Disease →
Sponsor
Neurocenter of Southern Switzerland
Who can join
35 and older, any sex, with Idiopathic Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep benefit (SB) is a prominent spontaneous, apparently unpredictable, transitory improvement in motor function reported by around 50% of patients affected by Parkinson's Disease (PD) after sleep and before taking their first dose of dopaminergic medications. This study aims at systematically characterizing SB in PD patients in an ecological setting and to explore the relationships between nocturnal and diurnal sleep and subjective and objective measures of motor function. A better understanding of this phenomenon is mandatory for future research on this topic.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The SleepFit Tablet Application for Home-Based Clinical Data Collection in Parkinson Disease: User-Centric Development and Usability Study.
Mascheroni A, Choe EK, Luo Y, Marazza M, et al · · 2021 · cited 4× · PMID 34100767 · DOI 10.2196/16304 -
A New Prospective, Home-Based Monitoring of Motor Symptoms in Parkinson's Disease.
Ratti PL, Faraci F, Hackethal S, Mascheroni A, et al · · 2019 · cited 4× · PMID 31476169 · DOI 10.3233/jpd-191662
Verify or expand the search:
- PubMed search for NCT02723396
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Idiopathic Parkinson Disease
Currently open trials in the same condition.
- NCT07023224 — Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26) · recruiting
- NCT04459052 — FDOPA PET and Nutritional Support in Parkinson's Disease · Phase 2 · active not recruiting
- NCT03683225 — A Study to Evaluate in Patients With Parkinsonian Type Disorders · Phase 2 · active not recruiting
Other Neurocenter of Southern Switzerland trials
Trials by the same sponsor.
- NCT03969602 — Cognitive Behavioral Therapy (CBT) After Lumbar Spinal Fusion in Patients With High Pain Catastrophizing · NA · unknown
- NCT03681327 — Sleep Infra-slow Oscillations III · NA · completed
- NCT02710487 — Sleep, Awake & Move - Part II · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02723396 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neurocenter of Southern Switzerland
- Last refreshed: 13 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02723396.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing